VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,389 | -34.6% | 24,887 | +0.0% | 0.00% | – |
| Q2 2023 | $164,095 | -2.9% | 24,882 | -0.1% | 0.00% | – |
| Q1 2023 | $169,002 | +105.3% | 24,908 | +123.5% | 0.00% | – |
| Q4 2022 | $82,315 | -25.2% | 11,146 | -50.0% | 0.00% | – |
| Q3 2022 | $110,110 | -9.7% | 22,292 | +100.3% | 0.00% | – |
| Q2 2022 | $122,000 | -74.4% | 11,130 | -73.5% | 0.00% | – |
| Q1 2022 | $476,000 | +172.0% | 42,073 | +277.8% | 0.00% | – |
| Q4 2021 | $175,000 | -82.7% | 11,136 | -85.6% | 0.00% | – |
| Q4 2020 | $1,014,000 | +50.7% | 77,171 | +10.8% | 0.00% | – |
| Q3 2020 | $673,000 | -6.8% | 69,660 | +10.4% | 0.00% | – |
| Q2 2020 | $722,000 | +111.7% | 63,106 | +92.0% | 0.00% | – |
| Q1 2020 | $341,000 | – | 32,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |